FI4114404T3 - Diabeettiseen perifeeriseen neuropatiaan liittyvän kivun hoitaminen - Google Patents
Diabeettiseen perifeeriseen neuropatiaan liittyvän kivun hoitaminen Download PDFInfo
- Publication number
- FI4114404T3 FI4114404T3 FIEP22731960.5T FI22731960T FI4114404T3 FI 4114404 T3 FI4114404 T3 FI 4114404T3 FI 22731960 T FI22731960 T FI 22731960T FI 4114404 T3 FI4114404 T3 FI 4114404T3
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical composition
- use according
- damaged area
- pain
- neuropathic pain
- Prior art date
Links
- 208000032131 Diabetic Neuropathies Diseases 0.000 title claims 6
- 208000002193 Pain Diseases 0.000 title claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 21
- 208000004296 neuralgia Diseases 0.000 claims 9
- 208000021722 neuropathic pain Diseases 0.000 claims 9
- 208000004454 Hyperalgesia Diseases 0.000 claims 5
- 239000006071 cream Substances 0.000 claims 3
- 230000008050 pain signaling Effects 0.000 claims 3
- 208000035824 paresthesia Diseases 0.000 claims 3
- 230000001953 sensory effect Effects 0.000 claims 3
- 208000024891 symptom Diseases 0.000 claims 3
- 208000014094 Dystonic disease Diseases 0.000 claims 2
- 206010070834 Sensitisation Diseases 0.000 claims 2
- 206010053552 allodynia Diseases 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 208000010118 dystonia Diseases 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000008313 sensitization Effects 0.000 claims 2
- 206010006784 Burning sensation Diseases 0.000 claims 1
- 206010017062 Formication Diseases 0.000 claims 1
- 208000003098 Ganglion Cysts Diseases 0.000 claims 1
- 208000035154 Hyperesthesia Diseases 0.000 claims 1
- 208000004044 Hypesthesia Diseases 0.000 claims 1
- 208000005400 Synovial Cyst Diseases 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 208000034783 hypoesthesia Diseases 0.000 claims 1
- 230000007372 neural signaling Effects 0.000 claims 1
- 231100000862 numbness Toxicity 0.000 claims 1
- 230000008058 pain sensation Effects 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 210000003497 sciatic nerve Anatomy 0.000 claims 1
- 230000035807 sensation Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 210000001032 spinal nerve Anatomy 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192248P | 2021-05-24 | 2021-05-24 | |
| PCT/US2022/072497 WO2022251806A1 (en) | 2021-05-24 | 2022-05-23 | Treating pain associated with diabetic peripheral neuropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI4114404T3 true FI4114404T3 (fi) | 2023-09-05 |
Family
ID=82115530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP22731960.5T FI4114404T3 (fi) | 2021-05-24 | 2022-05-23 | Diabeettiseen perifeeriseen neuropatiaan liittyvän kivun hoitaminen |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20240100073A1 (es) |
| EP (2) | EP4114404B1 (es) |
| JP (1) | JP2024520465A (es) |
| KR (1) | KR20240012356A (es) |
| CN (1) | CN117377475A (es) |
| AU (1) | AU2022280139A1 (es) |
| BR (1) | BR112023024426A2 (es) |
| CA (1) | CA3220196A1 (es) |
| DK (1) | DK4114404T3 (es) |
| ES (1) | ES2961829T3 (es) |
| FI (1) | FI4114404T3 (es) |
| HR (1) | HRP20230842T1 (es) |
| HU (1) | HUE062996T2 (es) |
| LT (1) | LT4114404T (es) |
| MA (1) | MA58890B1 (es) |
| MD (1) | MD4114404T2 (es) |
| MX (1) | MX2023013853A (es) |
| PL (1) | PL4114404T3 (es) |
| PT (1) | PT4114404T (es) |
| RS (1) | RS64402B1 (es) |
| SI (1) | SI4114404T1 (es) |
| WO (1) | WO2022251806A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024112725A1 (en) | 2022-11-23 | 2024-05-30 | Medicon Pharmaceuticals, Inc. | Treating pain associated with central sensitization |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2705463C (en) | 2007-08-10 | 2014-10-07 | Basil Rigas | Anti-inflammatory compounds and uses thereof |
| WO2013067591A1 (en) * | 2011-11-10 | 2013-05-16 | Relevare Australia Pty Ltd | Topical formulations for pain management |
| WO2013130625A1 (en) * | 2012-02-27 | 2013-09-06 | Basil Rigas | Phospho-ester derivatives and uses thereof |
| US20140315834A1 (en) * | 2012-09-21 | 2014-10-23 | Medicon Pharmaceuticals, Inc. | Compounds and compositions for use in the prevention and treatment of inflammation-related disorders, pain and fever, skin disorders, cancer and precancerous conditions thereof |
| US11510931B2 (en) * | 2016-09-28 | 2022-11-29 | Medicon Pharmaceuticals, Inc. | Compositions and methods for treating ophthalmic conditions |
| WO2019067919A1 (en) | 2017-09-28 | 2019-04-04 | Medicon Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERS |
| CN112955145A (zh) * | 2018-09-04 | 2021-06-11 | 密涅瓦神经科学有限公司 | 使用苯氧丙胺化合物治疗疼痛的方法 |
-
2022
- 2022-05-23 KR KR1020237035329A patent/KR20240012356A/ko unknown
- 2022-05-23 RS RS20230612A patent/RS64402B1/sr unknown
- 2022-05-23 MD MDE20230065T patent/MD4114404T2/ro unknown
- 2022-05-23 MA MA58890A patent/MA58890B1/fr unknown
- 2022-05-23 CA CA3220196A patent/CA3220196A1/en active Pending
- 2022-05-23 SI SI202230005T patent/SI4114404T1/sl unknown
- 2022-05-23 EP EP22731960.5A patent/EP4114404B1/en active Active
- 2022-05-23 BR BR112023024426A patent/BR112023024426A2/pt unknown
- 2022-05-23 DK DK22731960.5T patent/DK4114404T3/da active
- 2022-05-23 CN CN202280037430.3A patent/CN117377475A/zh active Pending
- 2022-05-23 EP EP23185849.9A patent/EP4272826A3/en active Pending
- 2022-05-23 ES ES22731960T patent/ES2961829T3/es active Active
- 2022-05-23 AU AU2022280139A patent/AU2022280139A1/en active Pending
- 2022-05-23 HU HUE22731960A patent/HUE062996T2/hu unknown
- 2022-05-23 PT PT227319605T patent/PT4114404T/pt unknown
- 2022-05-23 WO PCT/US2022/072497 patent/WO2022251806A1/en active Application Filing
- 2022-05-23 HR HRP20230842TT patent/HRP20230842T1/hr unknown
- 2022-05-23 MX MX2023013853A patent/MX2023013853A/es unknown
- 2022-05-23 PL PL22731960.5T patent/PL4114404T3/pl unknown
- 2022-05-23 JP JP2023572983A patent/JP2024520465A/ja active Pending
- 2022-05-23 LT LTEPPCT/US2022/072497T patent/LT4114404T/lt unknown
- 2022-05-23 FI FIEP22731960.5T patent/FI4114404T3/fi active
-
2023
- 2023-11-21 US US18/515,743 patent/US20240100073A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK4114404T3 (da) | 2023-09-18 |
| KR20240012356A (ko) | 2024-01-29 |
| RS64402B1 (sr) | 2023-08-31 |
| MA58890B1 (fr) | 2023-08-31 |
| BR112023024426A2 (pt) | 2024-02-20 |
| WO2022251806A1 (en) | 2022-12-01 |
| JP2024520465A (ja) | 2024-05-24 |
| MX2023013853A (es) | 2023-12-08 |
| EP4114404A1 (en) | 2023-01-11 |
| PL4114404T3 (pl) | 2024-01-03 |
| HUE062996T2 (hu) | 2023-12-28 |
| ES2961829T3 (es) | 2024-03-14 |
| US20240100073A1 (en) | 2024-03-28 |
| PT4114404T (pt) | 2023-10-19 |
| AU2022280139A1 (en) | 2024-01-18 |
| CN117377475A (zh) | 2024-01-09 |
| EP4272826A3 (en) | 2024-01-17 |
| MD4114404T2 (ro) | 2024-01-31 |
| LT4114404T (lt) | 2023-11-10 |
| EP4114404B1 (en) | 2023-07-19 |
| SI4114404T1 (sl) | 2023-12-29 |
| CA3220196A1 (en) | 2022-12-01 |
| EP4272826A2 (en) | 2023-11-08 |
| HRP20230842T1 (hr) | 2023-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5854291A (en) | Pain reliever and method of use | |
| US4997853A (en) | Method and compositions utilizing capsaicin as an external analgesic | |
| FI4114404T3 (fi) | Diabeettiseen perifeeriseen neuropatiaan liittyvän kivun hoitaminen | |
| KR20090080017A (ko) | 건조각막결막염 경감 방법 | |
| MEP43008A (en) | Indole-2-carboxamides as factor xa inhibitors | |
| Lin et al. | Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study | |
| US20020146440A1 (en) | Mult-purpose skin balm including skin balm for psoriasis | |
| Jamir et al. | ZCPG, a cysteine protease from Zingiber montanum rhizome exhibits enhanced anti-inflammatory and acetylcholinesterase inhibition potential | |
| Malla et al. | Factors associated with involuntary admission to psychiatric facilities in Newfoundland. | |
| YU86101A (sh) | Inhibitori faktora viia | |
| FI4114403T3 (fi) | Solunsalpaajahoidon indusoimaan perifeeriseen neuropatiaan liittyvän neuropaattisen kivun hoitaminen | |
| CN110237122A (zh) | 一种外用药物及其制备方法和用途 | |
| CN114767729A (zh) | 季德胜蛇药物组合物或其制剂制备预防、缓解、辅助治疗或治疗面肌痉挛或内风的药物用途 | |
| Li et al. | Amides from Zanthoxylum bungeanum Maxim.(Rutaceae) are promising natural agents with neuroprotective activities | |
| JP3082994B2 (ja) | 美白化粧料 | |
| EP0646372A1 (de) | Capsaicin enthaltendes Arzneimittel zur Behandlung chronischer Rhinopathie | |
| TW202106322A (zh) | 舒眠精油組合物及其用途 | |
| CN111840403A (zh) | 一种用于耳鸣及具有健耳舒耳功能的滴耳剂 | |
| JP3819126B2 (ja) | 皮脂合成抑制用皮膚外用剤 | |
| JPH0570349A (ja) | 抗プラスミン剤 | |
| NO20021241L (no) | Farmasöytiske og/eller kosmetiske blandinger | |
| CN112315863B (zh) | 一种舒缓光电术中疼痛热感的组合物及制备方法和应用 | |
| CN110237229A (zh) | 一种减少皮肤色素及治疗疼痛度的中胚层疗法的药物组合物及其制备方法 | |
| Malec-Milewska | Postherpetic neuralgia (PHN) | |
| Mendoza-Madrigal et al. | Electroencephalographic profile of Salvia amarissima Ortega and amarisolide A in the absence and presence of PTZ-induced seizures in mice |